Determination of ivermectin B1a in animal plasma by liquid chromatography combined with electrospray ionization mass spectrometry

A novel, sensitive and specific method for the quantitative determination of ivermectin B1a in animal plasma using liquid chromatography combined with positive electrospray ionization tandem mass spectrometry (LC/ESI‐MS/MS) is presented. Abamectin was used as the internal standard. Extraction of the...

Full description

Saved in:
Bibliographic Details
Published inJournal of mass spectrometry. Vol. 37; no. 8; pp. 840 - 847
Main Authors Croubels, S., De Baere, S., Cherlet, M., De Backer, P.
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.08.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel, sensitive and specific method for the quantitative determination of ivermectin B1a in animal plasma using liquid chromatography combined with positive electrospray ionization tandem mass spectrometry (LC/ESI‐MS/MS) is presented. Abamectin was used as the internal standard. Extraction of the samples was performed with a deproteinization step using acetonitrile. Chromatographic separation was achieved on a Nucleosil ODS 5 µm column, using gradient elution with 0.2% (v/v) acetic acid in water and 0.2% (v/v) acetic acid in acetonitrile. The method was validated according to the requirements defined by the European Community. Calibration curves using plasma fortified between 1 and 100 ng ml−1 showed a good linear correlation (r ≥ 0.9989, goodness‐of‐fit coefficient ≤8.1%). The trueness at 2 and 25 ng ml−1 (n = 6) was +4.2 and −17.1%, respectively. The trueness and between‐run precision for the analysis of quality control samples at 25 ng ml−1 was −4.0 and 11.0%, respectively (n = 16). The limit of quantification of the method was 1.0 ng ml−1, for which the trueness and precision also fell within acceptable limits. Using a signal‐to‐noise ratio of 3 : 1, the limit of detection was calculated to be 0.2 ng ml−1. The specificity was demonstrated with respect to ivermectin B1b. The method was successfully used for the quantitative determination of ivermectin B1a in plasma samples from treated bovines, demonstrating the usefulness of the developed method for application in the field of pharmacokinetics. Copyright © 2002 John Wiley & Sons, Ltd.
Bibliography:ArticleID:JMS343
ark:/67375/WNG-V1W3HBN0-X
istex:BC80FE05DE7AC82C89E6C111A0F5C501E91AB20D
ISSN:1076-5174
1096-9888
DOI:10.1002/jms.343